Abstract
Therapeutic gene delivery systems offer the potential for the treatment of a range of inherited and acquired inherited diseases. In contrast with viral gene vectors, the nonviral gene vectors provide a safer alternative and additional advantages such as the improved delivery efficiency, low cost, and often unlimited capacity to package DNA. Here we describe the preparation of a nonviral gene delivery technique based on lipid–peptide–DNA (LPD) complexes. The size of LPD particles is in the nanometer range. The use of these nanoparticulate LPDs results in high efficiency transfections and a high level of gene expression in vitro. LPDs provide a convenient and efficient tool for gene delivery in gene therapy.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Emery DE (2004) Gene therapy for genetic diseases: on the horizon. Clin Appl Immunol Rev 4:411–422
Hashida M, Nishikawa M, Yamashita F, Takakura Y (2001) Cell-specific delivery of genes with glycosylated carriers. Adv Drug Deliv Rev 52:187–196
Naldini L (2015) Gene therapy returns to Centre stage. Nature 526:351–360
Dunbar CE, High KA, Joung JK et al (2018) Gene therapy comes of age. Science 359:4672
Kay MA, Glorioso JC, Naldini L (2001) Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 7:33–40
Russell SJ, Peng K-W, Bell JC (2012) Oncolytic virotherapy. Nat Biotechnol 30:658–670
Huang S, Kamihira M (2013) Development of hybrid viral vectors for gene therapy. Biotechnol Adv 31:208–223
Yin H, Kanasty RL, Eltoukhy AA et al (2014) Non-viral vectors for gene-based therapy. Nat Rev Genet 15:541–555
Wang HY, Jiang YF, Peng HG et al (2015) Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors. Adv Drug Deliv Rev 81:142–160
Wang HX, Li M, Lee CM et al (2017) CRISPR/Cas9-based genome editing for disease modeling and therapy: challenges and opportunities for nonviral delivery. Chem Rev 117:9874–9906
Hardee CL, Arevalo-Soliz LM, Hornstein BD et al (2017) Advances in non-viral DNA vectors for gene therapy. Genes (Basel) 8:65
Lin G, Li L, Panwar N et al (2018) Non-viral gene therapy using multifunctional nanoparticles: status, challenges, and opportunities. Coord Chem Rev 374:133–152
Appaiahgari MB, Vrati S (2015) Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls. Expert Opin Biol Ther 15:337–351
Jayant RD, Sosa D, Kaushik A, Atluri V et al (2016) Current status of non-viral gene therapy for CNS disorders. Expert Opin Drug Deliv 13:1433–1445
Zabner J (1997) Cationic lipids used in gene transfer. Adv Drug Deliv Rev 27:17–28
Zhi D, Bai Y, Yang J et al (2018) A review on cationic lipids with different linkers for gene delivery. Adv Colloid Interface Sci 253:114–140
Pedroso de Lima MC, Simões S, Pires P et al (2001) Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications. Adv Drug Deliv Rev 47:277–294
Morille M, Passirani C, Vonarbourg A et al (2008) Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials 29:3477–3496
Xiang S, Tong H, Shi Q et al (2012) Uptake mechanisms of non-viral gene delivery. J Control Release 158:371–378
Remaut K, Sanders NN, Fayazpour F et al (2006) Influence of plasmid DNA topology on the transfection properties of DOTAP/DOPE lipoplexes. J Control Release 115:335–343
Kim BK, Hwang GB, Seu YB et al (2015) DOTAP/DOPE ratio and cell type determine transfection efficiency with DOTAP-liposomes. BBA-Biomembranes 1848:1996–2001
Zauner W, Farrow NA, Haines AM (2001) In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density. J Control Release 71:39–51
Tsai JT, Furstoss KJ, Michnick T et al (2002) Quantitative physical characterization of lipid-polycation-DNA lipoplexes. Biotechnol Appl Biochem 36:13–20
Acknowledgments
The manuscript was edited by Mikhail Soloviev.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Zhang, F., Li, HY. (2020). Preparation of Lipid–Peptide–DNA (LPD) Nanoparticles and Their Use for Gene Transfection. In: Ferrari, E., Soloviev, M. (eds) Nanoparticles in Biology and Medicine. Methods in Molecular Biology, vol 2118. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0319-2_6
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0319-2_6
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0318-5
Online ISBN: 978-1-0716-0319-2
eBook Packages: Springer Protocols